Table 5. Treatment for syphilis-exposed infants according to maternal syphilis seroprevalence (n = 115 countries*).
Maternal syphilis prevalence <1% (n = 73) | Maternal syphilis prevalence ≥1% (n = 42) | p-value | |
---|---|---|---|
Treatment for exposed infant according to WHO† guidelines (penicillin administration) | |||
Aqueous benzyl penicillin 100,000–150,000 U/kg/day IV for 10–15 days | 21 (29%) | 23 (55%) | 0.02 |
Procaine penicillin 50,000 U/kg/day single dose IM for 10–15 days | 57 (78%) | 26 (62) | 0.06 |
BPG 50,000 U/kg/day as single IM dose | 59 (81%) | 27 (64%) | 0.05 |
Follow-up of exposed infants described | |||
Infant non-treponemal tests at birth | 22 (30%) | 24 (57%) | <0.01 |
Infant non-treponemal tests at 6–12 week | 60 (82%) | 26 (62%) | 0.02 |
Follow up exam at 6–12 weeks | 20 (27%) | 23 (56%) | <0.01 |
*There were 13 countries with no available maternal syphilis seroprevalence data.
BPG = benzathine penicillin G.
†World Health Organization.